Aluminum-chloride-phthalocyanine encapsulated in liposomes: Activity against naturally occurring dog breast cancer cells

Journal of Biomedical Nanotechnology

Volumn 8, Issue 2, 2012, Pages 251-257

  Rocha, Martha S T ^a   Lucci, Carolina M ^a   Longo, João Paulo F ^a   Galera, Paula D ^a   Simioni, Andreza R ^b   Lacava, Zulmira G M ^a   Tedesco, Antônio C ^b   Azevedo, Ricardo B ^a  

^a UNIVERSITY OF BRASILIA   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Complex carcinoma; Female dog; Liposomes; Mammary gland; Photodynamic therapy

Indexed keywords

ACRIDINE ORANGE; ADJUVANT CHEMOTHERAPY; BREAST CANCER; BREAST CANCER CELLS; BREAST TUMOR; CANCER CELLS; CELL DESTRUCTION; CELL MORPHOLOGY; CELL VIABILITY; COMPLEX CARCINOMA; CURRENT TREATMENTS; ELECTRONIC MICROSCOPY; ETHIDIUM BROMIDE; FEMALE DOG; IN-VITRO; MALIGNANT TUMORS; MAMMARY GLAND; MORPHOLOGICAL ALTERATION; NATURALLY OCCURRING; SKIN CANCERS; TREATMENT MODALITY;

ALUMINUM; BROMINE COMPOUNDS; CHEMOTHERAPY; CHLORINE COMPOUNDS; CYTOLOGY; DISEASES; ELECTRON MICROSCOPY; LIGHT EMITTING DIODES; LIGHT SOURCES; LIPOSOMES; MORPHOLOGY; NITROGEN COMPOUNDS; PHOTODYNAMIC THERAPY; PHOTOSENSITIZERS; TUMORS;

CELLS;

ALUMINUM CHLORIDE PHTHALOCYANINE; LIPOSOME; PHOTOSENSITIZING AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL DESTRUCTION; CELL DEATH; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DOG; DRUG ACTIVITY; DRUG EFFICACY; ENCAPSULATION; IN VITRO STUDY; LIGHT EMITTING DIODE; LIPOSOMAL DELIVERY; NONHUMAN; PHOTODYNAMIC THERAPY;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL SURVIVAL; DOGS; FEMALE; INDOLES; LIPOSOMES; MAMMARY NEOPLASMS, ANIMAL; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, PHASE-CONTRAST; NECROSIS; NIH 3T3 CELLS; ORGANOMETALLIC COMPOUNDS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; TUMOR CELLS, CULTURED;

EID: 84861473446     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2012.1378     Document Type: Article

References (39)

1. M. Paoloni and C. Khanna, Translation of new cancer treatments from pet dogs to humans. Nature Reviews Cancer 8, 147 (2008).
2. S. J. Withrow and D. M. Vail, Withrow and MacEwen's small animal clinical oncology, WB Saunders Company, Philadelphia, PA, (2007).
3. T. Itoh, K. Uchida, K. Ishikawa, K. Kushima, E. Kushima, H. Tamada, T. Moritake, H. Nakao, and H. Shii, Clinicopathological survey of 101 canine mammary gland tumors: Differences between small-breed dogs and others. J. Vet. Med. Sci. 67, 345 (2005).
4. D. M. Vail, Supporting the veterinary cancer patient on chemotherapy: Neutropenia and gastrointestinal toxicity. Topics in Companion Animal Medicine 24, 122 (2009).
5. R. Ackroyd, C. Kelty, N. Brown, and M. Reed, The history of photodetection and photodynamic therapy. Photochemistry and photobiology 74, 656 (2001).
6. T. J. Dougherty, C. J. Gomer, G. Jori, D. Kessel, M. Korbelik, J. Moan, and Q. Peng, Photodynamic therapy. Journal of the National Cancer Institute 90, 889 (1998).
7. L. R. Braathen, R. M. Szeimies, N. Basset-Seguin, R. Bissonnette, P. Foley, D. Pariser, R. Roelandts, A. M. Wennberg, and C. A. Morton, Guidelines on the use of photodynamic therapy for non-melanoma skin cancer: An international consensus. Journal of the American Academy of Dermatology 56, 125 (2007).
8. D. E. Dolmans and R. K. J. Dai Fukumura, Photodynamic therapy for cancer. Nat. Rev. Cancer 3, 380 (2003).
9. L. Santos Bicalho, J. P. Figueiró Longo, L. Oliveira Pereira, M. Meneses de Almeida Santos, and R. B. Azevedo, Photodynamic therapy, a new approach in the treatment of oral cancer. Revista Salud UIS 42, 167 (2011).
10. J. Piette, C. Volanti, A. Vantieghem, J. Y. Matroule, Y. Habraken, and P. Agostinis, Cell death and growth arrest in response to photodynamic therapy with membrane-bound photosensitizers. Biochemical Pharmacology 66, 1651 (2003).
11. N. L. Oleinick, R. L. Morris, and I. Belichenko, The role of apoptosis in response to photodynamic therapy: What, where, why, and how. Photochemical and Photobiological Sciences 1, 1 (2002).
12. R. R. Allison and C. H. Sibata, Oncologic photodynamic therapy photosensitizers: A clinical review. Photodiagnosis and Photodynamic Therapy 7, 61 (2011).
13. S. Verma, G. M. Watt, Z. Mai, and T. Hasan, Strategies for enhanced photodynamic therapy effects. Photochemistry and photobiology 83, 996 (2007).
14. S. I. Moriwaki, J. Misawa, Y. Yoshinari, I. Yamada, M. Takigawa, and Y. Tokura, Analysis of photosensitivity in Japanese cancer bearing patients receiving photodynamic therapy with porfimer sodium (PhotofrinTM), Photodermatology. Photoimmunology & Photomedicine 17, 241 (2001).
15. S. M. T. Nunes, F. S. Sguilla, and A. C. Tedesco, Photophysical studies of zinc phthalocyanine and chloroaluminum phthalocyanine incorporated into liposomes in the presence of additives. Brazilian Journal of Medical and Biological Research 37, 273 (2004).
16. Y. N. Konan, R. Gurny, and E. Allemann, State of the art in the delivery of photosensitizers for photodynamic therapy. Journal of Photochemistry and Photobiology B: Biology 66, 89 (2002).
17. A. S. L. Derycke and P. A. M. de Witte, Liposomes for photodynamic therapy. Advanced Drug Delivery Reviews 56, 17 (2004).
18. V. P. Torchilin, Recent advances with liposomes as pharmaceutical carriers. Nat. Rev. Drug Discovery 4, 145 (2005).
19. P. A. Barbugli, M. P. Siqueira-Moura, E. M. Espreafico, and A. C. Tedesco, In vitro phototoxicity of liposomes and nanocapsules containing chloroaluminum phthalocyanine on human melanoma cell line. Journal of Nanoscience and Nanotechnology 10, 569 (2011).
20. B. Kosmider, E. Zyner, R. Osiecka, and J. Ochocki, Induction of apoptosis and necrosis in A549 cells by the cis-Pt(II) complex of 3-aminoflavone in comparison with cis-DDP. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 563, 61 (2004).
21. R. I. Freshney, Culture of Animal Cells: A Manual of Basic Technique, John Wiley and Sons, Inc. (1994).
22. W. G. Roberts, M. K. Klein, M. Loomis, S. Weldy, and M. W. Berns, Photodynamic therapy of spontaneous cancers in felines, canines, and snakes with chloro-aluminium sulfonated phthalocyanine. Journal of the National Cancer Institute 83, 18 (1991).
23. A. E. Peaston, M. W. Leach, and R. J. Higgins, Photodynamic therapy for nasal and aural squamous cell carcinoma in cats. Journal of the American Veterinary Medical Association 202, 1261 (1993).
24. M. W. Leach and A. E. Peaston, Adverse drug reaction attributable to aluminum phthalocyanine tetrasulphonate administration in domestic cats. Veterinary Pathology Online 31, 283 (1994).
25. J. P. F.Longo, S. P. Lozzi, A. R. Simioni, P. C. Morais, A. C. Tedesco, and R. B. Azevedo, Photodynamic therapy with aluminum-chloro-phtalocyanine induces necrosis and vascular damage in mice tongue tumors. Journal of Photochemistry & Photobiology, B: Biology 94, 143 (2009).
26. E. C. C. Tapajós, J. P. Longo, A. R. Simioni, Z. G. M. Lacava, M. Santos, P. C. Morais, A. C. Tedesco, and R. B. Azevedo, In vitro photodynamic therapy on human oral keratinocytes using chloroaluminum-phthalocyanine. Oral Oncology 44, 1073 (2008).
27. S. Anand, G. Honari, T. Hasan, P. Elson, and E. V. Maytin, Low-dose methotrexate enhances aminolevulinate-based photodynamic therapy in skin carcinoma cells in vitro and in vivo. Clinical Cancer Research 15, 3333 (2009).
28. L. M. Moreira, F. V. dos Santos, J. P. Lyon, M. Maftoum-Costa, C. Pacheco-Soares, and N. S. da Silva, Photodynamic therapy: Porphyrins and phthalocyanines as photosensitizers. Australian Journal of Chemistry 61, 741 (2008).
29. K. W. Woodburn, Q. Fan, D. Kessel, M. Wright, T. D. Mody, G. Hemmi, D. Magda, J. L. Sessler, W. C. Dow, and R. A. Miller, Phototherapy of cancer and atheromatous plaque with texaphyrins. Journal of clinical laser medicine & surgery 14, 343 (1996).
30. C. Wising, J. Azem, M. Zetterberg, L. A. Svensson, K. Ahlman, and T. Lagergård, Induction of apoptosis/necrosis in various human cell lineages by Haemophilus ducreyi cytolethal distending toxin. Toxicon. 45, 767 (2005).
31. D. V. Krysko, T. Vanden Berghe, K. D'Herde, and P. Vandenabeele, Apoptosis and necrosis: Detection, discrimination and phagocytosis. Methods 44, 205 (2008).
32. R. D. Almeida, B. J. Manadas, A. P. Carvalho, and C. B. Duarte, Intracellular signaling mechanisms in photodynamic therapy. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1704, 59 (2004).
33. A. P. Ribeiro, A. C. Pavarina, F. Z. Trindade, N. M. Inada, V. S. Bagnato, and C. C. A. de Souza, Photodynamic therapy associating Photogem and blue LED on L929 and MDPC-23 cell culture. Cell Biology International 34, 343 (2010).
34. S. Spörri, V. Chopra, N. Egger, H. K. Hawkins, M. Motamedi, E. Dreher, and H. Schneider, Effects of 5-aminolaevulinic acid on human ovarian cancer cells and human vascular endothelial cells in vitro. Journal of Photochemistry and Photobiology B: Biology 64, 8 (2001).
35. F. Rancan, A. Wiehe, M. Nobel, M. O. Senge, S. A. Omari, F. Bohm, M. John, and B. Roder, Influence of substitutions on asymmetric dihydroxychlorins with regard to intracellular uptake, subcellular localization and photosensitization of Jurkat cells. Journal of Photochemistry and Photobiology B: Biology 78, 17 (2005).
36. D. E. Dolmans and R. K. Jain, Photodynamic therapy for cancer. Nat. Rev. Cancer 3, 380 (2003).
37. A. P. Castano, P. Mroz, and M. R. Hamblin, Photodynamic therapy and anti-tumour immunity. Nat. Rev. Cancer 6, 535 (2006).
38. R. E. Cuenca, R. R. Allison, C. Sibata, and G. H. Downie, Breast cancer with chest wall progression: Treatment with photodynamic therapy. Annals of Surgical Oncology 11, 322 (2004).
39. R. Allison, T. Mang, G. Hewson, W. Snider, and D. Dougherty, Photodynamic therapy for chest wall progression from breast carcinoma is an underutilized treatment modality. Cancer 91, 1 (2001).